Beta-Kdo disaccharide molecule and preparation method thereof
Through the glycosylation reaction of the Kdo alkyneoate donor with the β-Kdo acceptor, combined with triphenylphosphine oxide regulation, β-Kdo-(2→4)-β-Kdo and β-Kdo-( 2→8)-β-Kdo disaccharide solves the problems of stereoselectivity and separation difficulty in the prior art, and realizes efficient preparation of β-Kdo disaccharide.
Patent Information
- Application Number
- CN202411173578.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-12-03
AI Technical Summary
Since the 3-position of Kdo is a deoxygenated structure and lacks a stereo-guiding group, it is difficult to control the stereoselectivity of glycosylation, resulting in the generated product often being a α/β mixture with close polarity, reducing the glycosylation yield and separation difficulty.
The Kdo alkyneoate donor regulated by triphenylphosphine oxide and the β-Kdo acceptor are glycosylated in an organic solvent. Through a series of deprotection operations, β-Kdo-(2→4)- was finally produced. β-Kdo and β-Kdo-(2→8)-β-Kdo disaccharides.
It has achieved efficient construction of a single configuration of β-Kdo disaccharide, with mild reaction conditions, simple operation and high yield, and overcomes the problems of stereoselectivity and separation difficulty in the prior art.
Smart Images

Figure CN119060105A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedical materials, and particularly relates to a β-Kdo disaccharide molecule and a preparation method thereof. Background Art
[0002] 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) is an acidic octose located on the surface of bacteria. Natural Kdo has two configurations of glycosides, α- and β-. α-Kdo glycosides are mainly distributed in the core oligosaccharides of lipopolysaccharide (LPS) of Gram-negative bacteria, while β-Kdo glycosides are mainly distributed in capsular polysaccharides (CPS), extracellular polysaccharides (EPS) and O-antigens of lipopolysaccharides. For example, different β-Kdo oligosaccharide fragments are contained in the capsular polysaccharides of Escherichia coli, Actinobacillus pleuropneumoniae, Burkholderia oklahoma, Neisseria meningitidis, Rhizobium, Sinorhizobium meliloti, and the O-antigen of lipopolysaccharide of Providencia alcaligenes, Titania sakazakii, Raultorrhiza solani, Klebsiella pneumoniae, Aeromonas hydrophila, and Serratia marcescens. Lipopolysaccharide and capsular polysaccharide are considered to be important virulence factors closely related to the immune system, so glycosides containing β-Kdo are important potential targets for the development of carbohydrate-based vaccines, therapeutic agents, and diagnostic tools.
[0003] Affected by the structure of Kdo itself, it is very challenging to selectively construct β-Kdo glycosides with a single configuration. Since the 3-position of Kdo is a deoxygenated structure and lacks a stereo-directing group, it is impossible to form a neighboring group participation effect, making it difficult to control the stereoselectivity of Kdo glycosylation. Therefore, the generated product is often an α / β mixture with very close polarity; in addition, the 1-position carboxyl group of Kdo not only increases the steric hindrance, but its electron-withdrawing effect also reduces the activity of the Kdo donor, and it is very easy to generate sugar ene byproducts. These factors greatly reduce the glycosylation yield and further increase the difficulty of separating the glycosylation products.
[0004] In view of this, the present invention proposes a glycosidation reaction of a Kdo alkyne enoate donor regulated by triphenylphosphine oxide to efficiently construct β-Kdo disaccharide molecules, specifically β-Kdo-(2→4)-β-Kdo disaccharide and β-Kdo-(2→8)-β-Kdo disaccharide. Summary of the invention
[0005] In view of the problems existing in the prior art, the present invention aims to provide a β-Kdo disaccharide molecule and a preparation method thereof.
[0006] In order to achieve the above object, the present invention adopts the following technical solution:
[0007] The first aspect of the present invention provides a β-Kdo disaccharide molecule, wherein the β-Kdo disaccharide molecule is a β-Kdo-(2→4)-β-Kdo disaccharide or a β-Kdo-(2→8)-β-Kdo disaccharide, wherein the structural formulas of the β-Kdo-(2→4)-β-Kdo disaccharide and the β-Kdo-(2→8)-β-Kdo disaccharide are shown in the following formula (I) and formula (II):
[0008]
[0009] The second aspect of the present invention provides a method for preparing the above-mentioned β-Kdo disaccharide molecule, wherein the β-Kdo disaccharide molecule is β-Kdo-(2→4)-β-Kdo disaccharide, comprising the following steps:
[0010] S1. A fully acetylated Kdo alkyne ester donor having a structural formula as shown in the following formula (III) and a 7,8-O-propylidene-β-Kdo acceptor having a structural formula as shown in the following formula (IV) are dissolved in an organic solvent A, and a glycosylation reaction is carried out under the action of triphenylphosphine (trifluoromethanesulfonic acid) gold and triphenylphosphine oxide to obtain a β-Kdo-(2→4)-β-Kdo disaccharide derivative having a structural formula as shown in the following formula (V);
[0011]
[0012] S2, dissolving the obtained β-Kdo-(2→4)-β-Kdo disaccharide derivative in an organic solvent B, reacting under the action of acetic acid, removing the propylidene protecting group, and obtaining an intermediate VI having a structural formula shown in the following formula (VI);
[0013]
[0014] S3, dissolving the obtained intermediate VI in an organic solvent C, and performing a saponification reaction under the action of sodium hydroxide to remove the acetyl and ethyl ester protecting groups to obtain an intermediate VII having a structural formula (VII) as shown below;
[0015]
[0016] S4. The obtained intermediate VII is dissolved in an organic solvent D, and subjected to a hydrogenation reaction under the action of palladium hydroxide to remove the benzyl and benzyloxycarbonyl protecting groups to obtain β-Kdo-(2→4)-β-Kdo disaccharide.
[0017] Preferably, in step S1, the molar ratio of the fully acetylated Kdo alkyne enoate donor III, 7,8-O-propylidene-β-Kdo acceptor, triphenylphosphine (trifluoromethanesulfonic acid) gold and triphenylphosphine oxide is (1-2):(1-1.2):(0.3-0.5):(6-6.5); the temperature of the glycosidation reaction is -40°C; and the organic solvent A is toluene.
[0018] Preferably, in step S2, the concentration of the solution obtained by dissolving the β-Kdo-(2→4)-β-Kdo disaccharide derivative in the organic solvent B is 0.005-0.01 mmol / mL; the reaction temperature is 70° C.; and the organic solvent B is 80% acetic acid aqueous solution.
[0019] Preferably, in step S3, the concentration of the solution obtained by dissolving the intermediate VI in the organic solvent C is 0.003-0.01 mmol / mL; the temperature of the saponification reaction is room temperature; the organic solvent C is a solution obtained by mixing methanol, 1,4-dioxane and 1M sodium hydroxide solution, wherein the volume ratio of methanol, 1,4-dioxane and 1M sodium hydroxide solution is 1:(0.8-1):(2-2.5).
[0020] Preferably, in step S4, the concentration of the solution obtained by dissolving the intermediate VII in the organic solvent D is 0.003-0.01 mmol / mL; the temperature of the hydrogenation reaction is room temperature; the organic solvent D is a mixed solution of tetrahydrofuran, water and acetic acid, and the volume ratio of tetrahydrofuran, water and acetic acid is (1.8-2):1:(0.04-0.05).
[0021] The third aspect of the present invention provides a method for preparing the above-mentioned β-Kdo-(2→8)-β-Kdo disaccharide, wherein the β-Kdo disaccharide molecule is β-Kdo-(2→8)-β-Kdo disaccharide, comprising the following steps:
[0022] A1. A fully acetylated Kdo alkyne ester donor having a structural formula as shown in the following formula (III) and a 4,5-O-propylidene-β-Kdo acceptor having a structural formula as shown in the following formula (VIII) are dissolved in an organic solvent A, and a glycosylation reaction is carried out under the action of triphenylphosphine (trifluoromethanesulfonic acid) gold and triphenylphosphine oxide to obtain a β-Kdo-(2→8)-β-Kdo disaccharide derivative having a structural formula as shown in the following formula (IX);
[0023]
[0024] A2, dissolving the obtained β-Kdo-(2→8)-β-Kdo disaccharide derivative in an organic solvent B, reacting under the action of acetic acid, removing the propylidene protecting group, and obtaining an intermediate X with a structural formula shown in the following formula (X);
[0025]
[0026] A3, dissolving the obtained intermediate X in an organic solvent C, and performing a saponification reaction under the action of sodium hydroxide to remove the acetyl and ethyl ester protecting groups to obtain an intermediate XI having a structural formula (XI) as shown below;
[0027]
[0028] A4, dissolving the obtained intermediate XI in an organic solvent D, and performing a hydrogenation reaction under the action of palladium hydroxide to remove the benzyl and benzyloxycarbonyl protecting groups to obtain β-Kdo-(2→8)-β-Kdo disaccharide;
[0029] Preferably, in step A1, the molar ratio of the fully acetylated Kdo alkyne enoate donor, 4,5-O-propylidene-β-Kdo acceptor, triphenylphosphine (trifluoromethanesulfonic acid) gold and triphenylphosphine oxide is (1-2):(1-1.2):(0.3-0.5):(6-6.5); the temperature of the glycosidation reaction is -40°C; the organic solvent A is toluene;
[0030] Preferably, in step A2, the concentration of the solution obtained by dissolving the β-Kdo-(2→8)-β-Kdo disaccharide derivative in the organic solvent B is 0.005-0.01 mmol / mL; the reaction temperature is 70° C.; and the organic solvent B is 80% acetic acid aqueous solution.
[0031] Preferably, in step A3, the concentration of the solution obtained by dissolving the intermediate X in the organic solvent C is 0.003-0.01 mmol / mL; the temperature of the saponification reaction is room temperature; the organic solvent C is a solution obtained by mixing methanol, 1,4-dioxane and 1M sodium hydroxide solution, wherein the volume ratio of methanol, 1,4-dioxane and 1M sodium hydroxide solution is 1:(0.8-1):(2-2.5).
[0032] Preferably, in step A4, the concentration of the solution obtained by dissolving the intermediate XI in the organic solvent D is 0.003-0.01 mmol / mL; the temperature of the hydrogenation reaction is room temperature; the organic solvent D is a mixed solution of tetrahydrofuran, water and acetic acid, and the volume ratio of tetrahydrofuran, water and acetic acid is (1.8-2):1:(0.04-0.05).
[0033] The present invention has the following beneficial effects:
[0034] The present invention provides a novel β-Kdo disaccharide molecule and a preparation method thereof. Specifically, a fully acetylated Kdo alkyne alkene ester donor is firstly used to carry out a glycosylation reaction with a β-Kdo receptor in an organic solvent at a certain temperature under the action of triphenylphosphine (trifluoromethanesulfonic acid) gold (as a catalyst) and triphenylphosphine oxide (as an additive) to obtain a β-Kdo disaccharide derivative; then the obtained β-Kdo disaccharide derivative is sequentially subjected to a three-step deprotection operation of removing a propylidene protecting group, removing an acetyl group and an ethyl ester protecting group by a saponification reaction, and removing a benzyl group and a benzyloxycarbonyl protecting group by a hydrogenation reaction, and finally the β-Kdo disaccharide molecule is obtained, specifically β-Kdo-(2→4)-β-Kdo disaccharide and β-Kdo-(2→8)-β-Kdo disaccharide. In addition, the preparation method of the present invention has mild reaction conditions, simple operation, and high yield. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0036] Figure 1 The chemical structural formulas of β-Kdo-(2→4)-β-Kdo disaccharide and β-Kdo-(2→8)-β-Kdo disaccharide provided by the present invention;
[0037] Figure 2 A synthetic route for the β-Kdo-(2→4)-β-Kdo disaccharide provided by the present invention;
[0038] Figure 3 The present invention provides a synthetic route for the β-Kdo-(2→8)-β-Kdo disaccharide. DETAILED DESCRIPTION
[0039] In the following description, for the purpose of illustration rather than limitation, specific details such as specific system structures and technologies are provided to provide a thorough understanding of the embodiments of the present invention. However, it should be clear to those skilled in the art that the present invention may also be implemented in other embodiments without these specific details.
[0040] Example 1
[0041] Reference Figure 1-2 , synthesize β-Kdo-(2→4)-β-Kdo disaccharide, the specific route is as follows:
[0042]
[0043] Specific steps: (1) fully acetylated Kdo acetylene ester donor (113.8 mg, 0.20 mmol), 7,8-O-propylidene-β-Kdo acceptor (61.6 mg, 0.10 mmol), triphenylphosphine oxide (167.0 mg, 0.60 mmol) and newly activated Molecular sieves (200.0 mg) were dissolved in dry toluene (4.0 mL), stirred at -40 ° C for 30 min, and PPh3AuOTf dichloromethane solution (500 μL, 0.1 M) was added under argon protection, and stirred at -40 ° C for 12 h. After TLC showed that the reaction was complete, it was filtered, concentrated, and silica gel column chromatography (petroleum ether / ethyl acetate: 1 / 1) was used to obtain β-Kdo-(2→4)-β-Kdo disaccharide derivative (57.8 mg, 56%, β only);
[0044] (2) The β-Kdo-(2→4)-β-Kdo disaccharide derivative (40.8 mg, 0.038 mmol) was dissolved in 80% acetic acid solution (8.0 mL), and heated under reflux at 70°C for 3 h under argon protection. After TLC showed that the reaction was complete, the mixture was concentrated and subjected to silica gel column chromatography (dichloromethane / methanol: 10 / 1) to obtain intermediate VI (35.0 mg, 89%). The intermediate VI obtained by the above reaction was dissolved in a mixed solvent of methanol / 1,4-dioxane / 1M sodium hydroxide solution (2.0 mL / 2.0 mL / 4.0 mL), and stirred at room temperature for 3 h under argon protection. After TLC showed that the reaction was complete, the mixture was diluted with methanol and precipitated with Amberlite IR120 H + The resin was adjusted to neutral pH, filtered, concentrated, and RP-18 reverse phase silica gel column chromatography (methanol) to obtain intermediate VII (23.8 mg, 92%); the obtained intermediate VII was dissolved in a mixed solvent of tetrahydrofuran / water / acetic acid (4.8 mL / 2.4 mL / 96 μL), Pd(OH)2 / C (400.0 mg, 10%) was added, and hydrogenated at room temperature and atmospheric pressure for 24 hours. After TLC showed that the reaction was complete, the filter membrane was filtered, concentrated, and RP-18 reverse phase silica gel column chromatography (methanol / water: 1 / 9) was used to obtain β-Kdo-(2→4)-β-Kdo disaccharide (16.8 mg, 99%).
[0045] The β-Kdo-(2→4)-β-Kdo disaccharide derivatives were characterized and the results were as follows: [α] 25 D = +33.7 (c 0.30, CHCl3); 1H NMR (400MHz, CDCl3) δ7.36-7.15 (m, 10H), 5.26 (s, 1H), 5.16 (d, J = 9.6Hz, 2H), 5.09 (ddd ,J=1.6,2.8,9.6Hz,1H),4.84(ddd,J=3.2,4.4,13.2Hz,1H,H-4),4.64(dd,J=3.6,12.8 Hz,1H),4.48(d,J=2.4Hz,2H),4.39-4.24(m,5H),4.22-4.18(m,1H),4.16-4.11(m,2H) ,4.04(s,1H),3.94(dd,J=1.2,12.4Hz,1H),3.84(ddd,J=3.2,4.8,12.8Hz,1H),3.67(br s,1H),3.53(d,J=8.8Hz,1H),3.32-3.17(m,3H),2.39(dd,J=4.4,12.4Hz,1H,H-3e),2.22-2.16(m,2H), 2.13(s,3H),2.09(s,3H),2.05-2.01(m,4H),1.98(s,3H),1.49(m,4H),1.41(s,3H),1.37-1.25(m,11H); 13 C NMR (150MHz, CDCl3) δ170.6,170.4,170.0,169.9,168.5,167.5,156.9,156.3,138.1,137.1 ,136.9,128.7,128.6,128.5,128.1,128.0,127.5,127.4,127.3,109.7,100.0,99.4,74.8,7 3.2,71.7,70.6,68.5,67.5,67.3,67.0,66.6,64.1,63.9,62.6,61.8,61.4,50.6,50.3,47.2 ,46.2,32.9,32.7,29.5,28.0,27.6,26.8,25.4,23.4,21.0,20.9,20.8,14.3; HRMS(ESI)m / z calcd for C 51 H 69 O 21 NNa[M+Na] + 1054.4260, found 1054.4261.
[0046] The characterization results of β-Kdo-(2→4)-β-Kdo disaccharide are as follows: [α] 25 D = +22.6 (c0.50, H2O);1 H NMR (400MHz, D2O) δ4.19 (s, 1H), 3.96 (d, J = 2.0Hz, 1H), 3.93-3.82 (m, 5H), 3.77-3.67 (m ,4H),3.61(dd,J=9.6,11.2Hz,2H),3.42(dt,J=6.4,8.8Hz,1H),3.00(t,J=7.6Hz,2H),2 .45(dd,J=4.8,12.4Hz,1H,H-3e),2.35(dd,J=4.4,12.0Hz,1H,H-3'e),1.86(t,J=12.4H z,1H),1.82(t,J=12.4Hz,1H),1.71-1.62(m,2H),1.61-1.54(m,2H),1.45-1.38(m,2H); 13 CNMR(150MHz,D2O)δ181.5,102.2,101.1,73.4,72.9,72.1,69.0,68.9,67.3,65. 3,65.2,64.3,64.1,64.0,39.3,35.1,33.6,28.2,26.2,23.2,22.1; HRMS(ESI)m / z calcd forC 21 H 37 O 15 NNa[M+Na] + 566.2061, found 566.2060.
[0047] Example 2
[0048] Reference Figure 1 and Figure 3 , synthesize β-Kdo-(2→8)-β-Kdo disaccharide, the specific route is as follows:
[0049]
[0050] Specific steps: (1) fully acetylated Kdo acetylene ester donor III (113.8 mg, 0.20 mmol), 4,5-O-propylidene-β-Kdo acceptor 61.6 mg, 0.10 mmol), triphenylphosphine oxide (167.0 mg, 0.60 mmol) and newly activated Molecular sieves (200.0 mg) were dissolved in dry toluene (4.0 mL) and stirred at -40°C for 30 min. Under argon protection, a freshly prepared dichloromethane solution of PPh3AuOTf (500 μL, 0.1 M) was added and stirred at -40°C for 12 h. After TLC showed that the reaction was complete, the mixture was filtered, concentrated, and subjected to silica gel column chromatography (petroleum ether / ethyl acetate: 1 / 1) to obtain a β-Kdo-(2→8)-β-Kdo disaccharide derivative (55.8 mg, 54%, βonly).
[0051] (2) The β-Kdo-(2→8)-β-Kdo disaccharide derivative (40.3 mg, 0.039 mmol) was dissolved in 80% acetic acid solution (8.0 mL), and heated under reflux at 70°C for 3 h under argon protection. After TLC showed that the reaction was complete, the mixture was concentrated and subjected to silica gel column chromatography (dichloromethane / methanol: 10 / 1) to obtain intermediate X (37.5 mg, 97%). The intermediate X obtained by the above reaction was dissolved in a mixed solvent of methanol / 1,4-dioxane / 1M sodium hydroxide solution (2.0 mL / 2.0 mL / 4.0 mL), and stirred at room temperature for 3 h under argon protection. After TLC showed that the reaction was complete, the mixture was diluted with methanol and precipitated with Amberlite IR120 H + The resin was adjusted to neutral pH, filtered, concentrated, and RP-18 reverse phase silica gel column chromatography (methanol) to obtain intermediate XI (28.8 mg, 99%). The intermediate XI obtained by the above reaction was dissolved in a mixed solvent of tetrahydrofuran / water / acetic acid (4.8 mL / 2.4 mL / 96 μL), Pd(OH)2 / C (400.0 mg, 10%) was added, and hydrogenated at room temperature and atmospheric pressure for 24 hours. After TLC showed that the reaction was complete, the filter membrane was filtered, concentrated, and RP-18 reverse phase silica gel column chromatography (MeOH / H2O: 1 / 9) was used to obtain β-Kdo-(2→8)-β-Kdo disaccharide (20.1 mg, 99%).
[0052] The β-Kdo-(2→8)-β-Kdo disaccharide derivatives were characterized and the results were as follows: [α] 25 D = +34.0 (c 0.49, CHCl3); 1H NMR (400MHz, CDCl3) δ7.35-7.15(m,10H),5.30(s,1H),5.18-5.14(m,3H),4.92(ddd,J=3.2,4. 4,12.8Hz,1H,H-4),4.48-4.44(m,3H),4.42-4.14(m,9H),4.09-4.03(m,1H),3.64-3.54(m,3H) ,3.26-3.17(m,3H),2.73(d,J=4.4Hz,1H),2.41(dd,J=4.4,12.4Hz,1H,H-3e),2.19-2.13(m,2 H),2.09(s,3H),2.06(s,3H),2.04-2.02(m,1H),1.99(s,6H),1.51(m,4H),1.35-1.25(m,14H); 13 C NMR (150MHz, CDCl3) δ170.6,170.0,169.9,169.8,167.7,156.9,156.3,138.1,137.1,136 .9,128.7,128.6,128.5,128.0,127.9,127.4,127.3,109.4,99.7,98.5,72.3,71.3,71.1, 70.5,69.3,68.1,67.3,67.2,67.1,64.2,64.1,62.4,62.3,61.5,50.6,50.3,47.3,46.3,3 3.4,32.4,29.8,29.7,28.2,27.7,26.9,25.4,23.6,20.9,20.8,14.4,14.3; HRMS(ESI)m / z calcd for C 51 H 69 O 21 NNa[M+Na] + 1054.4260, found 1054.4261.
[0053] The characterization results of β-Kdo-(2→8)-β-Kdo disaccharide are as follows: [α] 25 D = +75.0 (c 0.48, H2O); 1H NMR(400MHz,D2O)δ4.14(dd,J=2.0,10.4Hz,1H),4.01(td,J=1.2,8.0Hz,1H),3.97-3.88 (m,4H),3.81-3.70(m,4H),3.63-3.61(m,2H),3.51-3.41(m,2H),3.02(t,J=7.6Hz,2H), 2.47(dd,J=4.8,12.4Hz,1H,H-3e),2.35(dd,J=4.4,12.0Hz,1H,H-3'e),1.86(t,J=12.4 Hz,1H),1.78(t,J=12.4Hz,1H),1.73-1.65(m,2H),1.63-1.59(m,2H),1.48-1.41(m,2H); 13 CNMR(150MHz,D2O)δ181.3,174.0,101.3,101.2,74.2,73.3,69.0,68.8,67.5,67.2,66.8, 65.7,65.3,64.0,61.5,39.3,34.8,34.5,28.2,27.8,26.2,23.1,22.0; HRMS(ESI)m / zcalcd for C 21 H 37 O 15 NNa[M+Na] + 566.2061, found 566.2063.
[0054] The present invention is not limited to the above-mentioned specific implementation modes. Various changes made by ordinary technicians in this field based on the above-mentioned concepts without creative work are all within the protection scope of the present invention.
Claims
1. β-Kdo disaccharide molecule, characterized in that The β-Kdo disaccharide molecule is β-Kdo-(2→4)-β-Kdo disaccharide or β-Kdo-(2→8)-β-Kdo, and the structural formulas of the β-Kdo-(2→4)-β-Kdo disaccharide and β-Kdo-(2→8)-β-Kdo disaccharide are shown in the following formula (I) and formula (II):
2. A method for preparing a β-Kdo disaccharide molecule as claimed in claim 1, wherein the β-Kdo disaccharide molecule is β-Kdo-(2→4)-β-Kdo disaccharide, characterized in that: The following steps are involved: S1. A fully acetylated Kdo alkyne ester donor having a structural formula as shown in the following formula (III) and a 7,8-O-propylidene-β-Kdo acceptor having a structural formula as shown in the following formula (IV) are dissolved in an organic solvent A, and a glycosylation reaction is carried out under the action of triphenylphosphine (trifluoromethanesulfonic acid) gold and triphenylphosphine oxide to obtain a β-Kdo-(2→4)-β-Kdo disaccharide derivative having a structural formula as shown in the following formula (V); S2, dissolving the obtained β-Kdo-(2→4)-β-Kdo disaccharide derivative in an organic solvent B, reacting with acetic acid to remove the propylidene protecting group, and obtaining an intermediate VI having a structural formula shown in the following formula (VI); S3, dissolving the obtained intermediate VI in an organic solvent C, and performing a saponification reaction under the action of sodium hydroxide to remove the acetyl and ethyl ester protecting groups to obtain an intermediate VII having a structural formula (VII) as shown below; S4. The obtained intermediate VII is dissolved in an organic solvent D, and subjected to a hydrogenation reaction under the action of palladium hydroxide to remove the benzyl and benzyloxycarbonyl protecting groups to obtain β-Kdo-(2→4)-β-Kdo disaccharide.
3. The method for preparing the β-Kdo disaccharide molecule according to claim 2, characterized in that: In step S1, the molar ratio of the fully acetylated Kdo alkyne enoate donor, 7,8-O-propylidene-β-Kdo acceptor, triphenylphosphine (trifluoromethanesulfonic acid) gold and triphenylphosphine oxide is (1-2):(1-1.2):(0.3-0.5):(6-6.5); the temperature of the glycosidation reaction is -40°C; and the organic solvent A is toluene.
4. The method for preparing the β-Kdo disaccharide molecule according to claim 2, characterized in that: In step S2, the concentration of the solution obtained by dissolving the β-Kdo-(2→4)-β-Kdo disaccharide derivative in the organic solvent B is 0.005-0.01 mmol / mL; the reaction temperature is 70° C.; and the organic solvent B is 80% acetic acid aqueous solution.
5. The method for preparing the β-Kdo disaccharide molecule according to claim 2, characterized in that: In step S3, the concentration of the solution obtained by dissolving the intermediate VI in the organic solvent C is 0.003-0.01 mmol / mL; the temperature of the saponification reaction is room temperature; the organic solvent C is a solution obtained by mixing methanol, 1,4-dioxane and 1M sodium hydroxide solution, wherein the volume ratio of methanol, 1,4-dioxane and 1M sodium hydroxide solution is 1:(0.8-1):(2-2.5).
6. The method for preparing the β-Kdo disaccharide molecule according to claim 2, characterized in that: In step S4, the concentration of the solution obtained by dissolving the intermediate VII in the organic solvent D is 0.003-0.01 mmol / mL; the temperature of the hydrogenation reaction is room temperature; the organic solvent D is a mixed solution of tetrahydrofuran, water and acetic acid, and the volume ratio of tetrahydrofuran, water and acetic acid is (1.8-2):1:(0.04-0.05).
7. A method for preparing a β-Kdo disaccharide molecule as claimed in claim 1, wherein the β-Kdo disaccharide molecule is β-Kdo-(2→8)-β-Kdo disaccharide, characterized in that: The following steps are involved: A1. A fully acetylated Kdo alkyne ester donor having a structural formula as shown in the following formula (III) and a 4,5-O-propylidene-β-Kdo acceptor having a structural formula as shown in the following formula (VIII) are dissolved in an organic solvent A, and a glycosylation reaction is carried out under the action of triphenylphosphine (trifluoromethanesulfonic acid) gold and triphenylphosphine oxide to obtain a β-Kdo-(2→8)-β-Kdo disaccharide derivative having a structural formula as shown in the following formula (IX); A2, dissolving the obtained β-Kdo-(2→8)-β-Kdo disaccharide derivative in an organic solvent B, reacting under the action of acetic acid, removing the propylidene protecting group, and obtaining an intermediate X with a structural formula shown in the following formula (X); A3, dissolving the obtained intermediate X in an organic solvent C, and performing a saponification reaction under the action of sodium hydroxide to remove the acetyl and ethyl ester protecting groups to obtain an intermediate XI having a structural formula (XI) as shown below; A4. The obtained intermediate XI is dissolved in an organic solvent D, and subjected to a hydrogenation reaction under the action of palladium hydroxide to remove the benzyl and benzyloxycarbonyl protecting groups to obtain β-Kdo-(2→8)-β-Kdo disaccharide.
8. The method for preparing β-Kdo disaccharide molecules according to claim 7, characterized in that: In step A1, the molar ratio of the fully acetylated Kdo alkyne enoate donor, 4,5-O-propylidene-β-Kdo acceptor, triphenylphosphine (trifluoromethanesulfonic acid) gold and triphenylphosphine oxide is (1-2):(1-1.2):(0.3-0.5):(6-6.5); the temperature of the glycosidation reaction is -40°C; the organic solvent A is toluene; In step A2, the concentration of the solution obtained by dissolving the β-Kdo-(2→8)-β-Kdo disaccharide derivative in the organic solvent B is 0.005-0.01 mmol / mL; the reaction temperature is 70° C.; and the organic solvent B is an 80% acetic acid aqueous solution.
9. The method for preparing β-Kdo disaccharide molecules according to claim 7, characterized in that: In step A3, the concentration of the solution obtained by dissolving the intermediate X in the organic solvent C is 0.003-0.01 mmol / mL; the temperature of the saponification reaction is room temperature; the organic solvent C is a solution obtained by mixing methanol, 1,4-dioxane and 1M sodium hydroxide solution, wherein the volume ratio of methanol, 1,4-dioxane and 1M sodium hydroxide solution is 1:(0.8-1):(2-2.5).
10. The method for preparing β-Kdo disaccharide molecules according to claim 7, characterized in that: In step A4, the concentration of the solution obtained by dissolving the intermediate XI in the organic solvent D is 0.003-0.01 mmol / mL; the temperature of the hydrogenation reaction is room temperature; the organic solvent D is a mixed solution of tetrahydrofuran, water and acetic acid, and the volume ratio of tetrahydrofuran, water and acetic acid is (1.8-2):1:(0.04-0.05).
